Cerebras Systems, the AI chipmaker that has spent years positioning itself as the anti-Nvidia, is finding out just how hungry Wall Street is for that pitch. The company has raised its IPO price range due to overwhelming investor demand, with the offering reportedly oversubscribed by more than 20 times.

Orders have exceeded $10 billion for the deal, which originally targeted a price range of $115 to $125 per share. That range was bumped to $125 to $135 as of May 8, with strong indications that pricing could climb even higher before shares begin trading on Nasdaq under the ticker CBRS.

The numbers behind the frenzy

Cerebras plans to sell 28 million shares, aiming to raise up to $3.5 billion in what would be one of the largest tech IPOs in recent memory. To put that in perspective, the company is trying to raise roughly the same amount that Arm Holdings pulled in during its blockbuster 2023 listing.

The company has also secured an $850 million credit facility, capital earmarked for expanding its data center footprint and deepening partnerships with major AI players.

Those partnerships are a key part of the bull case. Cerebras has been collaborating with OpenAI and Amazon, two names that carry enormous weight in the AI infrastructure conversation. The company has built its reputation on the claim that its wafer-scale chips deliver superior performance compared to Nvidia’s offerings, particularly for large language model training and inference workloads.

Why investors are piling in

Cerebras is different in at least one measurable way: it actually has revenue-generating relationships with the companies building frontier AI models. Working with OpenAI, the maker of ChatGPT, and Amazon, which runs one of the three major cloud platforms, gives Cerebras a credibility moat that most competitors lack.

The company’s core technology is also genuinely unusual. While most AI chips are roughly the size of a postage stamp, Cerebras builds chips the size of a dinner plate. In English: they take an entire silicon wafer, the kind that normally gets sliced into hundreds of individual chips, and turn it into one massive processor. The result is a chip with far more compute cores and memory bandwidth than anything Nvidia sells as a single unit.

A 20x oversubscription means that for every share available, investors have placed orders for 20. That level of demand typically forces pricing upward, which is exactly what has happened here.

What this means for investors

Cerebras faces a few specific risks worth watching. First, customer concentration. Partnerships with OpenAI and Amazon are impressive, but heavy reliance on a small number of massive customers creates vulnerability. If either relationship cools, the revenue impact would be significant.

Second, there is the Nvidia problem. Nvidia is not standing still. Its Blackwell architecture and upcoming Rubin platform represent moving targets that every AI chip startup must outrun. Cerebras may have a performance edge today, but maintaining that lead requires relentless R&D spending, which is presumably why the company wants $3.5 billion in IPO proceeds plus an $850 million credit facility.

For investors who cannot access IPO allocation, the first-day premium could be steep given the oversubscription dynamics. Those considering buying in the secondary market should weigh whether the valuation implied by a $125 to $135 range, potentially higher, is justified by Cerebras’ current revenue run rate and growth trajectory relative to its AI chip peers.